Cannabinoid Compositions
Compositions for administering cannabinoid, including edible forms of cannabinoids. Phospholipids and waxes may be used to control the onset timing of cannabis drug effects.
1 . A composition for administering cannabinoid, comprising approximately the following percentages by weight:
8.0% lecithin fraction enriched with phospholipids;
8.0% vitamin E;
0.4% lemon oil;
75.3% glycerin; and
8.3% ethanol.
2 . The composition of claim 1 wherein the phospholipids are comprised of at least 50% Phosphatidylcholine.
3 . The composition of claim 2 further comprising 10 milligrams of delta-9-tetrahydrocannabinol.
4 . The composition of claim 3 , wherein the composition comprises 20 moles of lecithin fraction enriched with at least 85% phosphatidylcholine for each mole of delta-9-tetrahydrocannabinol.
5 . The composition of claim 1 wherein the phospholipids are comprised of at least 85% phosphatidylcholine.
6 . The composition of claim 5 further comprising 10 milligrams of delta-9-tetrahydrocannabinol.
7 . The composition of claim 6 , wherein the composition comprises 20 moles of lecithin fraction enriched with at least 85% phosphatidylcholine for each mole of delta-9-tetrahydrocannabinol.
8 . A composition for administering cannabinoid, comprising approximately the following percentages by weight:
26% lecithin fraction enriched with phospholipids;
26% vitamin E TPGS;
12% polysorbate 80;
5% cannabinoids; and
31% ethanol.
9 . The composition of claim 9 wherein the phospholipids are comprised of at least 50% phosphatidylcholine.
10 . The composition of claim 9 wherein the phospholipids are comprised of at least 85% phosphatidylcholine.